GSK is scheduled to report results for the second quarter on Tuesday. Here is what you need to know. TURNOVER FORECAST: Analysts expect the U.K. drugmaker to generate turnover of 8.24 billion pounds ...
GSK plc is a leading global biopharmaceutical company with a diversified portfolio of vaccines and specialty medicines. The company focuses on innovation-driven growth, long-term research investment, ...
GSK plc has agreed to acquire US cancer biotech Nuvalent for about 10.6 billion USD in cash, aiming to accelerate its oncology pipeline and lung-cancer portfolio. What this means for the London-listed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results